06:55 AM EDT, 07/30/2025 (MT Newswires) -- United Therapeutics ( UTHR ) reported Q2 net income Wednesday of $6.41 per diluted share, up from $5.85 a year earlier.
Analysts polled by FactSet expected $6.94.
Revenue for the quarter ended June 30 was $798.6 million, compared with $714.9 million a year earlier.
Analysts surveyed by FactSet expected $803.6 million.